Using nanotechnology to improve cancer treatment

Dec 03, 2010 BY WILLIAM G. GILROY

(PhysOrg.com) -- Research directed by Basar Bilgicer, assistant professor of chemical and biomolecular engineering and a member of the Advanced Diagnostics and Therapeutics initiative at the University of Notre Dame, could one day enable clinicians to deliver powerful chemotherapy drugs to tumors without deleterious side effects.

Although chemotherapeutic agents are poisonous to tumors, they also can kill healthy , leading to .

Bilgicer’s research involves developing drug- loaded nanoparticles to target the tumor tissue, so that the chemotherapeutic agents can be delivered specifically to the tumors rather than healthy tissue.

This video is not supported by your browser at this time.

His studies are based on the fact that nanoparticles accumulated in the tumor tissue, whose leaky blood vessels allowed the nanoparticles to pass out of the capillaries that feed the tumor. While the nanoparticles are small enough to penetrate the tumor tissue, they are too large to pass into other tissues in vital organs such as the kidneys, lungs, liver or spleen. Once the molecule is firmly lodged in the tumor, the higher acidity of the tumor environment causes the release of the chemotherapeutic load, thereby dumping its toxicity fully on cancerous tissues rather than traveling to healthy cells.

Although Bilgicer’s studies have primarily been in blood cancers, he notes that the nanoparticles also have application in lung and breast cancers. The nanoparticles will require further development and clinical trials before they are ready for patient care.

Bilgicer will be collaborating with Rudolph Navari, director of Notre Dame’s Walter Cancer Institute and assistant dean of the Indiana University School of Medicine South Bend, to study the compound’s possible uses in oncology treatment.

Explore further: Nanocontainers for nanocargo: Delivering genes and proteins for cellular imaging, genetic medicine and cancer therapy

add to favorites email to friend print save as pdf

Related Stories

Using nanotechnology to improve a cancer treatment

Jun 28, 2010

(PhysOrg.com) -- Harvard and Brigham and Women’s Hospital researchers have devised a method that may allow clinicians to use higher doses of a powerful chemotherapy drug that has been limited because it is toxic not only ...

Nano-Vehicle acts as cluster bomb for tumors

Sep 18, 2010

Chemotherapy, while an effective cancer treatment, also brings debilitating side effects such as nausea, liver toxicity, and a battered immune system. Now, a new way to deliver this life-saving therapy to cancer patients ...

A more direct delivery of cancer drugs to tumors

Apr 21, 2009

(PhysOrg.com) -- An interdisciplinary team of researchers at Brigham and Women’s Hospital (BWH) and the Harvard-MIT Division of Health Sciences and Technology (HST) has demonstrated a better way to deliver ...

Recommended for you

Twisted graphene chills out

11 hours ago

(Phys.org) —When two sheets of graphene are stacked in a special way, it is possible to cool down the graphene with a laser instead of heating it up, University of Manchester researchers have shown.

Researchers use liquid inks to create better solar cells

11 hours ago

(Phys.org) —The basic function of solar cells is to harvest sunlight and turn it into electricity. Thus, it is critically important that the film that collects the light on the surface of the cell is designed ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

joefarah
not rated yet Dec 04, 2010
What can be done to expedite this treatment option. A few $billion would be more than worth it for a successful treatment option. Time is of the essence though.